Asset profile
Capecitabine
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: HR+/HER2- Metastatic Breast Cancer (label: advanced or metastatic breast cancer, with no HR or HER2 restriction)
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
Featured evidence outside covered markets:LOMAC (NCT03399110) · Gastric Cancer · Phase 3 · completed · ungradedNCT01918527 · Colon Cancer · Phase 3 · completed · ungraded
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
60 competitors in this universe: 0 direct rivals (same mechanism and indication), 0 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Capecitabine: this drug | Approved | Small molecule | Fluoropyrimidine (antimetabolite) | ||
| Abemaciclib (Verzenio) | Approved | Small molecule | CDK4 and CDK6 | ||
| Alpelisib (BYL719) | Approved | Small molecule | PI3K-alpha | ||
| Anastrozole | Approved | Small molecule | Aromatase | ||
| Capivasertib | Approved | Small molecule | AKT (inhibitor) | ||
| Datopotamab Deruxtecan | Approved | Antibody–drug conjugate | TROP2 | ||
| Denosumab | Approved | Monoclonal antibody | RANKL | ||
| Docetaxel | Approved | Small molecule | Microtubules (tubulin) | ||
| Elacestrant | Approved | Small molecule | Estrogen receptor | ||
| Eribulin Mesylate | Approved | Small molecule | Tubulin / microtubules | ||
| Everolimus | Approved | Small molecule | mTOR kinase, mTOR (mTORC1) (inhibitor) | ||
| Exemestane | Approved | Small molecule | Aromatase | ||
| Fulvestrant (Faslodex) | Approved | Small molecule | Estrogen receptor | ||
| Gedatolisib | Approved | Small molecule | PI3K (class I isoforms) and mTORC1/mTORC2 | ||
| Gemcitabine | Approved | Small molecule | ribonucleotide reductase / DNA polymerase (dCTP competition) | ||
| Goserelin | Approved | Peptide | GnRH receptor (agonist) |
…and 45 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(289 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (46)
October 2026 (6)
Phase 2Colorectal Cancer Stage II, Colorectal Cancer Stage IIIActive not recruiting
Est. primary completion 2026-10-18 · NCT04304209 · CT.gov ↗
What to watch
Phase 1Colorectal CancerActive not recruiting
Est. primary completion 2026-10-23 · NCT05464030 · CT.gov ↗
What to watch
Phase 2Stomach Cancer, Gastro Esophageal Junction CancerActive not recruiting
Est. primary completion 2026-10-31 · NCT03448835 · CT.gov ↗
What to watch
Phase 1Locally Advanced Rectal CancerRecruiting
Est. primary completion 2026-10-31 · NCT05412082 · CT.gov ↗
What to watch
Phase 1Metastatic Colorectal Cancer (CRC)Recruiting
Est. primary completion 2026-10-31 · NCT06825624 · CT.gov ↗
What to watch
Early phase / not applicableLocally Advanced Rectal CancerRecruiting
Est. primary completion 2026-10-31 · NCT06894797 · CT.gov ↗
What to watch
November 2026 (12)
Phase 2Rectal CancerActive not recruiting
Est. primary completion 2026-11 · NCT02008656 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast Cancer, Breast CancerRecruiting
Est. primary completion 2026-11 · NCT04768426 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2026-11 · NCT06118333 · CT.gov ↗
What to watch
Phase 2GI CancersEnrolling by invitation
Est. primary completion 2026-11 · NCT06648785 · CT.gov ↗
What to watch
Phase 2MSI-H/dMMR Locally Advanced Rectal AdenocarcinomaRecruiting
Est. primary completion 2026-11 · NCT07750951 · CT.gov ↗
What to watch
Phase 1/2Breast, Metastatic, Triple Negative, Cancer, Disseminated Tumor CellRecruiting
Est. primary completion 2026-11-03 · NCT04333706 · CT.gov ↗
What to watch
Phase 2Biliary Malignant TumorsRecruiting
Est. primary completion 2026-11-15 · NCT06685289 · CT.gov ↗
What to watch
Phase 2Biliary Tract CarcinomaNot yet recruiting
Est. primary completion 2026-11-15 · NCT06699459 · CT.gov ↗
What to watch
Phase 2Advanced Colorectal CancerRecruiting
Est. primary completion 2026-11-27 · NCT06885385 · CT.gov ↗
What to watch
Phase 2Rectal Adenocarcinoma, Clinical Stage: Stage II (T3-4, N-), Stage III (Any T, N+), Solid Tumor, Solid Tumor, AdultRecruiting
Est. primary completion 2026-11-30 · NCT04165772 · CT.gov ↗
What to watch
Phase 1/2Metastatic Colorectal CancerRecruiting
Est. primary completion 2026-11-30 · NCT05093907 · CT.gov ↗
What to watch
Phase 2Gastrointestinal Neuroendocrine CarcinomaRecruiting
Est. primary completion 2026-11-30 · NCT06070740 · CT.gov ↗
What to watch
December 2026 (28)
Phase 1/2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2026-12 · NCT03377387 · CT.gov ↗
What to watch
Phase 3Cancer of RectumRecruiting
Est. primary completion 2026-12 · NCT04095299 · CT.gov ↗
What to watch
Phase 1/2Colorectal Cancer Metastatic, Peritoneal CarcinomatosisActive not recruiting
Est. primary completion 2026-12 · NCT05700656 · CT.gov ↗
What to watch
Phase 2Leptomeningeal Metastasis, Leptomeningeal Disease, HER2-positive Metastatic Breast CancerRecruiting
Est. primary completion 2026-12 · NCT05800275 · CT.gov ↗
What to watch
Phase 1Gastrointestinal CancerRecruiting
Est. primary completion 2026-12 · NCT06065371 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2026-12 · NCT06202261 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2026-12 · NCT06942767 · CT.gov ↗
What to watch
Phase 2Rectal Cancer PatientsRecruiting
Est. primary completion 2026-12-01 · NCT06647680 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer With Liver MetastasesRecruiting
Est. primary completion 2026-12-01 · NCT06787183 · CT.gov ↗
What to watch
Early phase / not applicableColorectal CarcinomaNot yet recruiting
Est. primary completion 2026-12-15 · NCT06115733 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer Stage IVActive not recruiting
Est. primary completion 2026-12-30 · NCT05171660 · CT.gov ↗
What to watch
Phase 2pMMR, MSS, MSI-L, Locally Advanced Rectal CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT05731726 · CT.gov ↗
What to watch
Phase 3Gastroesophageal Junction Adenocarcinoma, Gastric AdenocarcinomaActive not recruiting
Est. primary completion 2026-12-30 · NCT06206733 · CT.gov ↗
What to watch
Phase 1Locally Advanced Rectal Cancer (LARC)Active not recruiting
Est. primary completion 2026-12-30 · NCT06459869 · CT.gov ↗
What to watch
Phase 2/3Gastric CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT01924819 · CT.gov ↗
What to watch
Phase 2Rectal CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT01941641 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7, Stage IV Esophageal Cancer AJCC v7 …Recruiting
Est. primary completion 2026-12-31 · NCT03161522 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT03756298 · CT.gov ↗
What to watch
Early phase / not applicablePancreatic Cancer, Proton TherapyRecruiting
Est. primary completion 2026-12-31 · NCT04894643 · CT.gov ↗
What to watch
Early phase / not applicableAnal Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05838391 · CT.gov ↗
What to watch
Phase 2HER2-positive Breast Cancer, LMDRecruiting
Est. primary completion 2026-12-31 · NCT06016387 · CT.gov ↗
What to watch
Phase 3Triple-negative Breast CancerRecruiting
Est. primary completion 2026-12-31 · NCT06533384 · CT.gov ↗
What to watch
Phase 2Gastric CancerRecruiting
Est. primary completion 2026-12-31 · NCT06555471 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer, Hilar Cholangiocarcinoma, Distal CholangiocarcinomaActive not recruiting
Est. primary completion 2026-12-31 · NCT06717464 · CT.gov ↗
What to watch
Phase 2Rectal CancerRecruiting
Est. primary completion 2026-12-31 · NCT07068763 · CT.gov ↗
What to watch
Phase 2Rectal Cancer, Radiotherapy, Immunotherapy, ChemotherapyRecruiting
Est. primary completion 2026-12-31 · NCT07239466 · CT.gov ↗
What to watch
Phase 2Combined Hepatocellular-cholangiocarcinoma, Liver NeoplasmsNot yet recruiting
Est. primary completion 2026-12-31 · NCT07243951 · CT.gov ↗
What to watch
2027 (95)
January 2027 (6)
Phase 1HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification, Colorectal CancerActive not recruiting
Est. primary completion 2027-01 · NCT06328738 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-01 · NCT06741644 · CT.gov ↗
What to watch
Phase 2Biliary Tract Neoplasms ImmunotherapyRecruiting
Est. primary completion 2027-01-01 · NCT07679399 · CT.gov ↗
What to watch
Phase 3Locally Advanced Unresectable or Metastatic Gastric Cancer …Recruiting
Est. primary completion 2027-01-11 · NCT06177041 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CarcinomaNot yet recruiting
Est. primary completion 2027-01-15 · NCT06759090 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-01-15 · NCT06764940 · CT.gov ↗
What to watch
February 2027 (5)
Phase 2Colorectal CancerNot yet recruiting
Est. primary completion 2027-02 · NCT07229846 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-02-20 · NCT06239727 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-02-26 · NCT06208410 · CT.gov ↗
What to watch
Phase 2Liver MetastasesRecruiting
Est. primary completion 2027-02-28 · NCT05062317 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerRecruiting
Est. primary completion 2027-02-28 · NCT05929885 · CT.gov ↗
What to watch
March 2027 (4)
Phase 3HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-03-01 · NCT05172518 · CT.gov ↗
What to watch
Phase 3HER2-negative Breast Cancer, Triple Negative Breast CancerActive not recruiting
Est. primary completion 2027-03-30 · NCT04595565 · CT.gov ↗
What to watch
Phase 2Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 …Recruiting
Est. primary completion 2027-03-31 · NCT05040360 · CT.gov ↗
What to watch
Phase 2Rectal CancerRecruiting
Est. primary completion 2027-03-31 · NCT07104604 · CT.gov ↗
What to watch
April 2027 (9)
Phase 2Pancreatic CancerActive not recruiting
Est. primary completion 2027-04 · NCT03523312 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-04 · NCT06409390 · CT.gov ↗
What to watch
Phase 2Solid Tumors, Children, AdolescentsRecruiting
Est. primary completion 2027-04-01 · NCT06761417 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer ResectableNot yet recruiting
Est. primary completion 2027-04-01 · NCT06888674 · CT.gov ↗
What to watch
Phase 1Rectal AdenocarcinomaRecruiting
Est. primary completion 2027-04-14 · NCT04808323 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2027-04-14 · NCT06247995 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal CancerNot yet recruiting
Est. primary completion 2027-04-24 · NCT05794750 · CT.gov ↗
What to watch
Phase 1/2Gastrointestinal CancerRecruiting
Est. primary completion 2027-04-30 · NCT07056777 · CT.gov ↗
What to watch
Phase 2Advanced Rectal CancerRecruiting
Est. primary completion 2027-04-30 · NCT07281157 · CT.gov ↗
What to watch
May 2027 (4)
Phase 2Advanced Rectal CancerRecruiting
Est. primary completion 2027-05-01 · NCT05228431 · CT.gov ↗
What to watch
Phase 2Gastric CancerActive not recruiting
Est. primary completion 2027-05-04 · NCT04379596 · CT.gov ↗
What to watch
Phase 2/3Colorectal (Colon or Rectal) CancerRecruiting
Est. primary completion 2027-05-12 · NCT07462143 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Liver Metastases (CRLM), Colorectal Cancer, Liver MetastasisNot yet recruiting
Est. primary completion 2027-05-30 · NCT07570914 · CT.gov ↗
What to watch
June 2027 (10)
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06 · NCT05342792 · CT.gov ↗
What to watch
Early phase / not applicableHR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-06 · NCT05876065 · CT.gov ↗
What to watch
Phase 1/2Colorectal CancerRecruiting
Est. primary completion 2027-06 · NCT07653685 · CT.gov ↗
What to watch
Phase 2Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid NeoplasmRecruiting
Est. primary completion 2027-06-01 · NCT03907475 · CT.gov ↗
What to watch
Phase 3Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer, HER2-positive Gastric CancerRecruiting
Est. primary completion 2027-06-01 · NCT06532006 · CT.gov ↗
What to watch
Phase 1/2Advanced CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04495296 · CT.gov ↗
What to watch
Phase 3Esophageal Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-06-30 · NCT04550260 · CT.gov ↗
What to watch
Phase 1Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v8 …Recruiting
Est. primary completion 2027-06-30 · NCT05803382 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-06-30 · NCT06942234 · CT.gov ↗
What to watch
Phase 1/2Advanced Pancreatic CancerRecruiting
Est. primary completion 2027-06-30 · NCT07692750 · CT.gov ↗
What to watch
July 2027 (4)
Phase 2Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2027-07-06 · NCT07051785 · CT.gov ↗
What to watch
Phase 4HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-07-07 · NCT07158164 · CT.gov ↗
What to watch
Phase 3Gastric CancerRecruiting
Est. primary completion 2027-07-21 · NCT04997837 · CT.gov ↗
What to watch
Early phase / not applicableHR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-07-30 · NCT06602167 · CT.gov ↗
What to watch
August 2027 (7)
Phase 2/3Adenocarcinoma of the RectumActive not recruiting
Est. primary completion 2027-08 · NCT02945566 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast CancerRecruiting
Est. primary completion 2027-08 · NCT04501523 · CT.gov ↗
What to watch
Phase 3Neuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3, Neuroendocrine Gastroenteropancreatic TumourRecruiting
Est. primary completion 2027-08-07 · NCT07185672 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal CancerRecruiting
Est. primary completion 2027-08-10 · NCT07469306 · CT.gov ↗
What to watch
Phase 2Colon CancerNot yet recruiting
Est. primary completion 2027-08-30 · NCT06790212 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-08-31 · NCT05693766 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer, Neoadjuvant TherapyRecruiting
Est. primary completion 2027-08-31 · NCT07150949 · CT.gov ↗
What to watch
September 2027 (13)
Phase 2Metastatic Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2027-09 · NCT05484375 · CT.gov ↗
What to watch
Phase 2Colorectal CarcinomaRecruiting
Est. primary completion 2027-09 · NCT06991465 · CT.gov ↗
What to watch
Phase 2Colorectal CancerActive not recruiting
Est. primary completion 2027-09 · NCT07215936 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2027-09-01 · NCT05851924 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-09-01 · NCT05976568 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal CancerRecruiting
Est. primary completion 2027-09-01 · NCT06204094 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2027-09-01 · NCT06560528 · CT.gov ↗
What to watch
Early phase / not applicablePancreatic CancerRecruiting
Est. primary completion 2027-09-01 · NCT06578052 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Liver MetastasisRecruiting
Est. primary completion 2027-09-01 · NCT06788171 · CT.gov ↗
What to watch
Phase 2Resectable Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-09-04 · NCT05265208 · CT.gov ↗
What to watch
Phase 1CarcinomaActive not recruiting
Est. primary completion 2027-09-27 · NCT01061515 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT02955940 · CT.gov ↗
What to watch
Phase 3Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint InhibitorsNot yet recruiting
Est. primary completion 2027-09-30 · NCT07132008 · CT.gov ↗
What to watch
October 2027 (8)
Phase 2CholangiocarcinomaNot yet recruiting
Est. primary completion 2027-10 · NCT07296666 · CT.gov ↗
What to watch
Phase 2Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Urothelial Cancer …Recruiting
Est. primary completion 2027-10-01 · NCT05489211 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsActive not recruiting
Est. primary completion 2027-10-14 · NCT06544655 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic …Recruiting
Est. primary completion 2027-10-20 · NCT07407465 · CT.gov ↗
What to watch
Phase 3Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2027-10-30 · NCT07043400 · CT.gov ↗
What to watch
Phase 1Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8 …Recruiting
Est. primary completion 2027-10-31 · NCT04615013 · CT.gov ↗
What to watch
Phase 1Colorectal CancerActive not recruiting
Est. primary completion 2027-10-31 · NCT06547385 · CT.gov ↗
What to watch
November 2027 (7)
Early phase / not applicableHypopharyngeal CarcinomaRecruiting
Est. primary completion 2027-11 · NCT05494190 · CT.gov ↗
What to watch
Phase 2Pseudomyxoma PeritoneiRecruiting
Est. primary completion 2027-11 · NCT06800391 · CT.gov ↗
What to watch
Phase 2Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8Recruiting
Est. primary completion 2027-11-05 · NCT06780787 · CT.gov ↗
What to watch
Phase 2Gastroesophageal AdenocarcinomaRecruiting
Est. primary completion 2027-11-09 · NCT07069712 · CT.gov ↗
What to watch
Phase 3Gastric / Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-11-17 · NCT07449780 · CT.gov ↗
What to watch
Phase 2Gastric CancerRecruiting
Est. primary completion 2027-11-30 · NCT05702229 · CT.gov ↗
What to watch
Phase 2Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene MutationRecruiting
Est. primary completion 2027-11-30 · NCT06123338 · CT.gov ↗
What to watch
December 2027 (18)
Phase 2Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 …Active not recruiting
Est. primary completion 2027-12 · NCT03073785 · CT.gov ↗
What to watch
Phase 2HER2 Expression Gastric Cancer/Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2027-12 · NCT05671822 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12 · NCT07007559 · CT.gov ↗
What to watch
Phase 1/2Rectal CancerRecruiting
Est. primary completion 2027-12 · NCT07561060 · CT.gov ↗
What to watch
Phase 1/2GC/GEJCNot yet recruiting
Est. primary completion 2027-12 · NCT07680569 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Carcinoma, Maintenance TherapyActive not recruiting
Est. primary completion 2027-12-20 · NCT05869227 · CT.gov ↗
What to watch
Phase 2Adenocarcinoma of Small Intestine, Appendix Carcinoma, MetastaticRecruiting
Est. primary completion 2027-12-30 · NCT05472948 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2027-12-30 · NCT05785741 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-12-30 · NCT07503756 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsActive not recruiting
Est. primary completion 2027-12-31 · NCT05502393 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Carcinoma, Local RecurrenceNot yet recruiting
Est. primary completion 2027-12-31 · NCT07331428 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor CancerRecruiting
Est. primary completion 2027-12-31 · NCT07477743 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-12-31 · NCT07490262 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07494448 · CT.gov ↗
What to watch
Phase 2ctDNA, Colorectal Cancer (CRC), Adjuvant ChemotherapyRecruiting
Est. primary completion 2027-12-31 · NCT07562659 · CT.gov ↗
What to watch
Phase 2Recurrent/ Metastatic NPCRecruiting
Est. primary completion 2027-12-31 · NCT07690787 · CT.gov ↗
What to watch
Phase 2Locally Advanced Colorectal Cancer, Colorectal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07691632 · CT.gov ↗
What to watch
Early phase / not applicableLocally Advanced Rectal Cancer (LARC)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07738042 · CT.gov ↗
What to watch
2028 (70)
January 2028 (9)
Phase 1Locally-advanced Rectal CancerRecruiting
Est. primary completion 2028-01-01 · NCT05912075 · CT.gov ↗
What to watch
Phase 2/3NPC, HNSCC, Recurrence, MetastasisNot yet recruiting
Est. primary completion 2028-01-01 · NCT06719479 · CT.gov ↗
What to watch
Phase 1/2Solid CancerActive not recruiting
Est. primary completion 2028-01-01 · NCT06771622 · CT.gov ↗
What to watch
Phase 3Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy, ImmunotherapyRecruiting
Est. primary completion 2028-01-01 · NCT07113275 · CT.gov ↗
What to watch
Phase 2Head Neck Cancer, Mouth Cancer, Throat Cancer, Larynx Cancer, Skin Cancer FaceNot yet recruiting
Est. primary completion 2028-01-01 · NCT07254962 · CT.gov ↗
What to watch
Phase 2Rectal CancerNot yet recruiting
Est. primary completion 2028-01-01 · NCT07774754 · CT.gov ↗
What to watch
Phase 2/3HER2-positive Breast Cancer, Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-01-16 · NCT07366840 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-01-30 · NCT07691333 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-01-31 · NCT07024615 · CT.gov ↗
What to watch
February 2028 (2)
March 2028 (7)
Phase 3HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-03-01 · NCT07684456 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma (Icc), Neoadjuvant TherapyRecruiting
Est. primary completion 2028-03-01 · NCT07847710 · CT.gov ↗
What to watch
Phase 3Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8 …Active not recruiting
Est. primary completion 2028-03-31 · NCT04248452 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2028-03-31 · NCT05034887 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine CarcinomaActive not recruiting
Est. primary completion 2028-03-31 · NCT05247905 · CT.gov ↗
What to watch
Early phase / not applicableRectal Cancer, AdenocarcinomaRecruiting
Est. primary completion 2028-03-31 · NCT07474103 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-03-31 · NCT07824869 · CT.gov ↗
What to watch
April 2028 (6)
Phase 2Locally Advanced Colorectal CancerNot yet recruiting
Est. primary completion 2028-04 · NCT07503639 · CT.gov ↗
What to watch
Phase 1/2NSCLC (Advanced Non-small Cell Lung Cancer), Colorectal Cancer, Advanced Solid TumorsNot yet recruiting
Est. primary completion 2028-04 · NCT07551778 · CT.gov ↗
What to watch
Phase 2Gastric Cancer (GC), AFP Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-04-01 · NCT07515625 · CT.gov ↗
What to watch
Phase 3Metastatic HER2-positive Breast CancerRecruiting
Est. primary completion 2028-04-28 · NCT06435429 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid TumorRecruiting
Est. primary completion 2028-04-30 · NCT06839105 · CT.gov ↗
What to watch
Phase 1/2Malignant Digestive System NeoplasmRecruiting
Est. primary completion 2028-04-30 · NCT07456852 · CT.gov ↗
What to watch
May 2028 (6)
Phase 2Locally Advanced Gastric Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-05-09 · NCT07621484 · CT.gov ↗
What to watch
Phase 3Gastric CarcinomaNot yet recruiting
Est. primary completion 2028-05-15 · NCT06944496 · CT.gov ↗
What to watch
Phase 2Colon CancerRecruiting
Est. primary completion 2028-05-30 · NCT06949111 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2028-05-30 · NCT07390383 · CT.gov ↗
What to watch
Phase 1Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2028-05-31 · NCT05365581 · CT.gov ↗
What to watch
Phase 3Esophageal Cancer, ChemoradiotherapyRecruiting
Est. primary completion 2028-05-31 · NCT07177794 · CT.gov ↗
What to watch
June 2028 (8)
Phase 1/2Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain, Glioblastoma, Adult, Brain Tumor, Brain Tumor, Primary, Brain Tumor Adult …Recruiting
Est. primary completion 2028-06 · NCT03213002 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-06 · NCT06105684 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, HER2-positive Gastric CancerNot yet recruiting
Est. primary completion 2028-06 · NCT07685704 · CT.gov ↗
What to watch
Early phase / not applicableCholangiocarcinomaNot yet recruiting
Est. primary completion 2028-06-01 · NCT06434493 · CT.gov ↗
What to watch
Phase 3HER2-positive Breast CancerRecruiting
Est. primary completion 2028-06-08 · NCT06992882 · CT.gov ↗
What to watch
Phase 3Gastric Cancer, Adjuvant Chemotherapy, XORecruiting
Est. primary completion 2028-06-30 · NCT01935778 · CT.gov ↗
What to watch
Phase 2HER2-positive Gastric CancerNot yet recruiting
Est. primary completion 2028-06-30 · NCT06998771 · CT.gov ↗
What to watch
Phase 2Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-06-30 · NCT07609667 · CT.gov ↗
What to watch
July 2028 (7)
Phase 3Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2028-07 · NCT07025239 · CT.gov ↗
What to watch
Phase 2Neuroendocrine Tumor Grade 2, Neuroendocrine TumorsRecruiting
Est. primary completion 2028-07-01 · NCT04339036 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer (LARC)Not yet recruiting
Est. primary completion 2028-07-01 · NCT07381777 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-07-01 · NCT07655661 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer (LARC), Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma …Not yet recruiting
Est. primary completion 2028-07-30 · NCT07243938 · CT.gov ↗
What to watch
Phase 2HER2-positive Breast Cancer, Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-07-31 · NCT07019337 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-07-31 · NCT07112053 · CT.gov ↗
What to watch
August 2028 (4)
Phase 2Triple Negative Breast NeoplasmsRecruiting
Est. primary completion 2028-08 · NCT05973864 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid Tumor Cancer, Triple-Negative Breast Cancer (TNBC), CNS Disease, Breast CancerNot yet recruiting
Est. primary completion 2028-08 · NCT07681297 · CT.gov ↗
What to watch
Phase 3High Risk Locally Advanced Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2028-08-20 · NCT06561763 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer (Diagnosis)Not yet recruiting
Est. primary completion 2028-08-31 · NCT07134101 · CT.gov ↗
What to watch
September 2028 (3)
Phase 3Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-09 · NCT07716449 · CT.gov ↗
What to watch
Phase 2/3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-09-01 · NCT04803539 · CT.gov ↗
What to watch
Phase 3Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer …Recruiting
Est. primary completion 2028-09-30 · NCT06901531 · CT.gov ↗
What to watch
October 2028 (2)
November 2028 (1)
Phase 3HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2028-11-20 · NCT06112379 · CT.gov ↗
What to watch
December 2028 (15)
Phase 2Pancreatic CancerActive not recruiting
Est. primary completion 2028-12 · NCT03351296 · CT.gov ↗
What to watch
Phase 2/3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-12 · NCT05288777 · CT.gov ↗
What to watch
Phase 2/3Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2028-12 · NCT06037980 · CT.gov ↗
What to watch
Phase 1/2Advanced Colorectal CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07737600 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2028-12-26 · NCT07331155 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma and Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2028-12-30 · NCT07384234 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12-30 · NCT07709767 · CT.gov ↗
What to watch
Phase 1Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8 …Active not recruiting
Est. primary completion 2028-12-31 · NCT04523818 · CT.gov ↗
What to watch
Phase 3Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-12-31 · NCT06622057 · CT.gov ↗
What to watch
Phase 2Recurrent Rectal CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT06751394 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-12-31 · NCT06787339 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT06963502 · CT.gov ↗
What to watch
Phase 4Rectal CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT07483060 · CT.gov ↗
What to watch
Phase 2Late-stage Resectable Esophageal Squamous CarcinomaRecruiting
Est. primary completion 2028-12-31 · NCT07622797 · CT.gov ↗
What to watch
Phase 3Gastric Adenocarcinoma and Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12-31 · NCT07677293 · CT.gov ↗
What to watch
2029 (32)
January 2029 (5)
Phase 2Rectal CancerNot yet recruiting
Est. primary completion 2029-01 · NCT07622017 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerActive not recruiting
Est. primary completion 2029-01-02 · NCT06109779 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-01-08 · NCT06324357 · CT.gov ↗
What to watch
Phase 2Breast Cancer, HER2-positive Breast CancerNot yet recruiting
Est. primary completion 2029-01-31 · NCT07417241 · CT.gov ↗
What to watch
Phase 3Gastric AdenocarcinomaRecruiting
Est. primary completion 2029-01-31 · NCT07584135 · CT.gov ↗
What to watch
February 2029 (3)
Phase 2Metastatic Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2029-02-01 · NCT07395063 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Cancer, Therapy-RelatedRecruiting
Est. primary completion 2029-02-20 · NCT05797077 · CT.gov ↗
What to watch
Phase 2Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaRecruiting
Est. primary completion 2029-02-28 · NCT07636824 · CT.gov ↗
What to watch
March 2029 (2)
April 2029 (3)
Phase 2Gastric Adenocarcinoma, Stomach NeoplasmsRecruiting
Est. primary completion 2029-04-01 · NCT07007182 · CT.gov ↗
What to watch
Phase 2Rectal CancerNot yet recruiting
Est. primary completion 2029-04-10 · NCT07509424 · CT.gov ↗
What to watch
Phase 3HER2-positive Gastric Cancer, Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2029-04-27 · NCT06764875 · CT.gov ↗
What to watch
May 2029 (2)
June 2029 (3)
Phase 2Triple Negative Breast CancerRecruiting
Est. primary completion 2029-06 · NCT06245889 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast CancerRecruiting
Est. primary completion 2029-06 · NCT06291064 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Carcinoma (NPC)Not yet recruiting
Est. primary completion 2029-06-01 · NCT06987123 · CT.gov ↗
What to watch
August 2029 (4)
Phase 2Gastric Cancer, HER2 + Gastric Cancer, CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, PD-L1 PositiveNot yet recruiting
Est. primary completion 2029-08-01 · NCT06881017 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-08-01 · NCT07631052 · CT.gov ↗
What to watch
Phase 3Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal CancerRecruiting
Est. primary completion 2029-08-16 · NCT07431281 · CT.gov ↗
What to watch
September 2029 (1)
Phase 1/2Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal CancerRecruiting
Est. primary completion 2029-09-12 · NCT06469944 · CT.gov ↗
What to watch
October 2029 (1)
Phase 1/2Advanced Colorectal Cancer (Part 1)Enrolling by invitation
Est. primary completion 2029-10-31 · NCT07683949 · CT.gov ↗
What to watch
December 2029 (8)
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-12-01 · NCT07222215 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharangeal CancerNot yet recruiting
Est. primary completion 2029-12-01 · NCT07238569 · CT.gov ↗
What to watch
Phase 1/2Colorectal CancerRecruiting
Est. primary completion 2029-12-01 · NCT07365592 · CT.gov ↗
What to watch
Phase 2/3Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2029-12-30 · NCT07251062 · CT.gov ↗
What to watch
Phase 2Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma, Anal Margin Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2029-12-31 · NCT04166318 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-12-31 · NCT06797635 · CT.gov ↗
What to watch
Phase 2Rectal Neoplasms MalignantNot yet recruiting
Est. primary completion 2029-12-31 · NCT07383285 · CT.gov ↗
What to watch
2030 (19)
January 2030 (2)
Phase 3Local Advanced Rectal Cancer, PD-1 Inhibitor, PCSK9 Inhibitor, RCT, Radiotherapy, Capecitabine, OxaliplatinNot yet recruiting
Est. primary completion 2030-01-01 · NCT07686796 · CT.gov ↗
What to watch
Phase 3Rectal CancerRecruiting
Est. primary completion 2030-01-30 · NCT06205485 · CT.gov ↗
What to watch
February 2030 (1)
Phase 3Nasopharyngeal Carcinoma, High-Risk Cancer, Maintenance TherapyRecruiting
Est. primary completion 2030-02-20 · NCT06277050 · CT.gov ↗
What to watch
March 2030 (3)
Phase 2Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal AdenocarcinomaRecruiting
Est. primary completion 2030-03 · NCT07432295 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2030-03-01 · NCT07392866 · CT.gov ↗
What to watch
Phase 2Locally Recurrent Rectal CancerRecruiting
Est. primary completion 2030-03-10 · NCT06928584 · CT.gov ↗
What to watch
May 2030 (1)
Phase 3Nasopharyngeal Carcinoma (NPC)Not yet recruiting
Est. primary completion 2030-05-01 · NCT06900218 · CT.gov ↗
What to watch
June 2030 (2)
July 2030 (2)
Phase 2Colorectal CancerRecruiting
Est. primary completion 2030-07 · NCT07281768 · CT.gov ↗
What to watch
Phase 2/3Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Locally Advanced Rectal AdenocarcinomaActive not recruiting
Est. primary completion 2030-07-01 · NCT05610163 · CT.gov ↗
What to watch
August 2030 (2)
September 2030 (1)
Phase 2/3Gastric or Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2030-09-01 · NCT06841679 · CT.gov ↗
What to watch
October 2030 (4)
Phase 3Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2030-10 · NCT07118527 · CT.gov ↗
What to watch
Phase 2Rectal CancerNot yet recruiting
Est. primary completion 2030-10 · NCT07580339 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2030-10-15 · NCT06525766 · CT.gov ↗
What to watch
Phase 3Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2030-10-21 · NCT06958328 · CT.gov ↗
What to watch
December 2030 (1)
Phase 3Nasopharyngeal Carcinoma (NPC)Recruiting
Est. primary completion 2030-12-31 · NCT07590024 · CT.gov ↗
What to watch
2031 (15)
February 2031 (2)
April 2031 (1)
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2031-04-10 · NCT06992336 · CT.gov ↗
What to watch
June 2031 (2)
Phase 2Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-positive Breast Cancer …Recruiting
Est. primary completion 2031-06-02 · NCT07340541 · CT.gov ↗
What to watch
Phase 1/2Triple Negative Breast Cancer, Residual DiseaseRecruiting
Est. primary completion 2031-06-26 · NCT06134375 · CT.gov ↗
What to watch
July 2031 (1)
Phase 2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2031-07-06 · NCT04383275 · CT.gov ↗
What to watch
September 2031 (3)
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2031-09 · NCT06313463 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC)Recruiting
Est. primary completion 2031-09 · NCT07154069 · CT.gov ↗
What to watch
Phase 2AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2031-09-15 · NCT04929028 · CT.gov ↗
What to watch
November 2031 (1)
Phase 3Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2031-11-07 · NCT03801876 · CT.gov ↗
What to watch
December 2031 (5)
Phase 3Nasopharyngeal Cancinoma (NPC)Active not recruiting
Est. primary completion 2031-12-31 · NCT07248670 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2031-12-31 · NCT07467330 · CT.gov ↗
What to watch
Phase 2Rectal Cancer PatientsNot yet recruiting
Est. primary completion 2031-12-31 · NCT07521605 · CT.gov ↗
What to watch
Phase 2Advanced Unresectable Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Advanced Gastroesophageal AdenocarcinomaRecruiting
Est. primary completion 2031-12-31 · NCT07554521 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2031-12-31 · NCT07766772 · CT.gov ↗
What to watch
2032 (4)
May 2032 (1)
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2032-05-31 · NCT06374459 · CT.gov ↗
What to watch
June 2032 (1)
Phase 2/3HER2-positive Gastric CancerNot yet recruiting
Est. primary completion 2032-06-30 · NCT07332533 · CT.gov ↗
What to watch
November 2032 (1)
Phase 3Colorectal CancerActive not recruiting
Est. primary completion 2032-11-01 · NCT07340567 · CT.gov ↗
What to watch
December 2032 (1)
Phase 3Locally Advanced Rectal Cancer (LARC), MSS (Microsatellite Stable)Not yet recruiting
Est. primary completion 2032-12-31 · NCT07551479 · CT.gov ↗
What to watch
2033 (3)
March 2033 (1)
Phase 3Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast NeoplasmsRecruiting
Est. primary completion 2033-03-23 · NCT06966700 · CT.gov ↗
What to watch
April 2033 (1)
Phase 3Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2033-04-01 · NCT05314998 · CT.gov ↗
What to watch
July 2033 (1)
Phase 3Biliary Tract Cancer (BTC)Not yet recruiting
Est. primary completion 2033-07-02 · NCT07745296 · CT.gov ↗
What to watch
2034 (1)
September 2034 (1)
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2034-09 · NCT06085742 · CT.gov ↗
What to watch
2035 (2)
June 2035 (1)
Phase 3Pancreatic Neuroendocrine Tumors (pNET), Pancreatic Neuroendocrine TumorsNot yet recruiting
Est. primary completion 2035-06 · NCT07591493 · CT.gov ↗
What to watch
September 2035 (1)
Phase 3Breast Cancer, Triple Negative Breast NeoplasmsActive not recruiting
Est. primary completion 2035-09 · NCT04335669 · CT.gov ↗
What to watch
2039 (1)
October 2039 (1)
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2039-10 · NCT02598349 · CT.gov ↗
What to watch
2040 (1)
June 2040 (1)
Phase 1/2Biliary Cancer, Bile Duct Cancer, Cancer of the Bile DuctRecruiting
Est. primary completion 2040-06-01 · NCT05849480 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.